Targeted radiation therapy for advanced cancer
Part of Cancer, Lungs & breathing clinical trials.
This study tests a new type of radiation therapy that targets a protein called CXCR4 on cancer cells. It is for people who have tried other treatments or have decided not to continue with them.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are able to make your own medical decisions and give consent.
- Your blood counts and kidney and liver function are at adequate levels.
- You have tried at least one standard treatment that did not work, or you have decided not to take further standard treatment.
- You have at least one tumor that is 2 cm or larger and shows the CXCR4 protein on a special scan.
- You are not pregnant or breastfeeding, and you agree to use birth control if needed.
- You have not had major surgery, another experimental drug, or certain cancer treatments within the past few weeks.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This Phase 3 study tests whether a targeted radiation treatment approach (using a special “PRRT” scan-guided method) works better to control advanced neuroendocrine tumors. It’s designed for tumors that show strong targeting on a specific PET scan and that are growing despite prior treatment (with some limits).
This trial tests a targeted radiation therapy approach for adults aged 75 and older whose cancer has advanced and standard treatments have stopped working or are not suitable. The goal is to see if this precise radiation can control the tumor with fewer side effects.
This trial tests a new type of PET scan that may help doctors see small cell lung cancer more clearly. It could improve treatment planning by showing where cancer has spread.
This trial tests if giving radiation to the main lung tumor before starting a targeted therapy pill can help delay the cancer from growing. It is for people with advanced non-small cell lung cancer that has a specific genetic change and who have not had targeted therapy before.
This trial is for people with advanced non-small cell lung cancer whose tumors responded well to initial chemo-immunotherapy. Instead of giving full chest radiation, doctors will only target the main tumor to see if it can prevent regrowth with fewer side effects.
This early study tests a new PET scan tracer (a radioactive imaging agent) that may light up a cell marker called CXCR4 in certain blood and solid tumor cancers. It may help doctors see where cancers are and how much CXCR4 they have, which could guide future treatments.
Hear when a new Carcinoid Tumor Lung trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.